Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens ...Middle East

The program can be an effective early warning system for public health and national security officials, leveraging voluntary nasal and wastewater sampling from international travelers at major U.S. airports BOSTON, Nov. 6, 2023 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and XWELL, Inc. (Nasdaq: XWEL) today announced they are expanding their work with the U.S. Centers for Disease Control and Prevention’s (CDC’s) Traveler-based Genomic Surveillance program (TGS) to test for more than 30 additional priority pathogens, in addition to SARS-CoV-2. TGS is a flexible, multimodal platform that consists of three complement

Hence then, the article about ginkgo bioworks and xwell implement expanded cdc traveler based genomic surveillance program to test for more than 30 known pathogens was published today ( Monday 06/11/2023 - 03:20 PM ) and is available on Bloomberg News Today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens )

Also on site :

• Ernest James Lattimer arrested for multiple sex crimes involving children who were attending an in-home childcare facility on Emerald Way
• Dunkin' Brings Back Highly Coveted Seasonal Flavor That Fans 'Really Needed Right Now'
• Lady Gaga Channels Community with 'Won't You Be My Neighbor?' Cover in Rocket and Redfin's Super Bowl LX Teaser